1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of North America Market by Service 41
3.1 Market Overview by Service 41
3.2 Genotyping 43
3.3 SNP Identification 44
3.4 Diagnostics 45
3.5 Other Services 47
4 Segmentation of North America Market by Technology 48
4.1 Market Overview by Technology 48
4.2 Polymerase Chain Reaction (PCR) 50
4.3 Microarray 51
4.4 Sequencing 52
4.5 Electrophoresis 53
4.6 Mass Spectrometry 54
4.7 Other Technologies 55
5 Segmentation of North America Market by Application 56
5.1 Market Overview by Application 56
5.2 Oncology 58
5.3 Infectious Diseases 59
5.4 Neurology/Psychiatry 60
5.5 Cardiovascular 62
5.6 Pain Management 63
5.7 Other Applications 64
6 Segmentation of North America Market by End User 65
6.1 Market Overview by End User 65
6.2 Hospitals and Clinics 67
6.3 Pharmaceutical Companies 68
6.4 Research Institutes 69
7 North America Market 2019-2030 by Country 70
7.1 Overview of North America Market 70
7.2 U.S. 73
7.3 Canada 77
7.4 Mexico 79
8 Competitive Landscape 81
8.1 Overview of Key Vendors 81
8.2 New Product Launch, Partnership, Investment, and M&A 85
8.3 Company Profiles 86
23andMe, Inc. 86
Abbott Laboratories 88
Admera Health, LLC 89
Agena Biosciences, Inc. 90
Astra Zeneca PLC 91
Bayer AG 92
Becton, Dickinson and Company 93
Cancer Genetics, Inc. 94
Dynamic DNA Laboratories 95
Empire Genomics LLC 96
F. Hoffmann-La Roche Ltd 97
geneOmbio Technologies Pvt Ltd. 98
Genomic Health, Inc. 99
Illumina, Inc. 100
Laboratory Corporation of America Holdings 101
Myriad Genetics Inc. 102
Oneome LLC 103
Opko Health, Inc. 104
Pathway Genomics Corporation 105
QIAGEN N.V. 106
Quest Diagnostics Incorporated 107
Teva Pharmaceuticals Industries Ltd. 108
Thermo Fisher Scientific Inc. 109
Transgenomic, Inc. 110
9 Investing in North America Market: Risk Assessment and Management 111
9.1 Risk Evaluation of North America Market 111
9.2 Critical Success Factors (CSFs) 114
Related Reports and Products 117